1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Contact Dermatitis in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (33.33) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FitzGerald, GA; Kaplan, MH; Ocana, JA; Pawelzik, SC; Romer, E; Sahu, R; Travers, JB | 1 |
| Al-Hassani, M; Konger, RL; Marathe, GK; Travers, JB; Wolverton, JE; Yao, Y; Zhang, Q | 1 |
| Konger, RL; Ocana, JA; Petrache, I; Rashid, BM; Sahu, RP; Tang, Y; Travers, JB; Turner, MJ; Van Demark, MJ; Yi, Q | 1 |
| Byrne, SN; Matsumura, Y; Miyahara, Y; Nghiem, DX; Ullrich, SE | 1 |
| Cai, S; Konger, RL; Pollok, KE; Sinn, AL; Travers, JB; Yao, Y; Zhang, Q | 1 |
| Byrne, SN; Fukunaga, A; Khaskhely, NM; Sreevidya, CS; Ullrich, SE | 1 |
| Archer, CB; MacDonald, DM; Morley, J; Page, CP; Paul, W | 1 |
| Auer, DE; Mills, PC; Ng, JC; Seawright, AA | 1 |
| Byrum, RS; Goulet, JL; Griffiths, RJ; Koller, BH; Snouwaert, JN | 1 |
| Andrews, MJ; Bailey, SR; Cunningham, FM; Elliott, J | 1 |
| Flower, RJ; Peers, SH | 1 |
| Braquet, P; Carré, C; Lavaud, P; Mencia-Huerta, JM; Rodrigue, F; Touvay, C | 1 |
| Braquet, P; Csató, M; Dobozy, A; Kemény, L | 1 |
| Cunningham, F; Greaves, MW; Kobza-Black, A; Ormerod, AD | 1 |
| Dubertret, L; Michel, L | 1 |
| Csatò, M; Czarnetzki, BM; Rosenbach, T | 1 |
| Csatò, M; Czarnetzki, BM | 1 |
| Archer, CB; MacDonald, DM; Morley, J; Page, CP | 1 |
18 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Contact Dermatitis
| Article | Year |
|---|---|
Platelet-Activating Factor-Induced Reduction in Contact Hypersensitivity Responses Is Mediated by Mast Cells via Cyclooxygenase-2-Dependent Mechanisms.
Topics: Animals; Carboxy-Lyases; Cell Movement; Cyclooxygenase 2; Dermatitis, Contact; Dinoprostone; Female; Immunosuppression Therapy; Lymph Nodes; Male; Mast Cells; Mice; Mice, Inbred C57BL; Platelet Activating Factor; Receptors, G-Protein-Coupled | 2018 |
Ultraviolet B radiation generated platelet-activating factor receptor agonist formation involves EGF-R-mediated reactive oxygen species.
Topics: Animals; Dermatitis, Contact; Epithelial Cells; ErbB Receptors; Humans; Immunosuppression Therapy; KB Cells; Mice; Mice, Hairless; Mice, Inbred C57BL; Platelet Activating Factor; Platelet Membrane Glycoproteins; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Skin; Ultraviolet Rays | 2009 |
Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists.
Topics: Animals; Antioxidants; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dermatitis, Contact; Dinitrofluorobenzene; Female; Forkhead Transcription Factors; Gene Expression; Glycerylphosphorylcholine; Hydrolases; Immunosuppression Therapy; Lipid Peroxidation; Lymphocyte Depletion; Mice; Mice, Transgenic; Nicotiana; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction; Smoke; T-Lymphocytes, Regulatory | 2013 |
A role for inflammatory mediators in the induction of immunoregulatory B cells.
Topics: Adoptive Transfer; Animals; Antigens, CD19; B-Lymphocytes; Dermatitis, Contact; Dihydropyridines; Flow Cytometry; Fluorescein-5-isothiocyanate; Immune Tolerance; Inflammation; Interleukin-10; Leukocyte Common Antigens; Lymphocyte Activation; Mice; Mice, Mutant Strains; Platelet Activating Factor; Serotonin; Serotonin Antagonists; Ultraviolet Rays | 2006 |
UVB radiation-mediated inhibition of contact hypersensitivity reactions is dependent on the platelet-activating factor system.
Topics: Animals; Cyclooxygenase 2; Dermatitis, Contact; Immune Tolerance; Interleukin-10; Mice; Mice, Inbred C57BL; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Ultraviolet Rays | 2008 |
Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response.
Topics: Amino Acid Sequence; Animals; Cell Movement; Dermatitis, Contact; Epidermal Cells; Epidermis; Keratinocytes; Langerhans Cells; Lymph Nodes; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Mice, Transgenic; Molecular Sequence Data; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Skin | 2008 |
Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin.
Topics: Adult; Dermatitis, Contact; Dinoprostone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Humans; Injections, Subcutaneous; Platelet Activating Factor; Prostaglandins E; Skin | 1984 |
Kinetics, dose response, tachyphylaxis and cross-tachyphylaxis of vascular leakage induced by endotoxin, zymosan-activated plasma and platelet-activating factor in the horse.
Topics: Animals; Capillary Permeability; Cell Movement; Complement C5a; Dermatitis, Contact; Dose-Response Relationship, Drug; Endothelium, Vascular; Endotoxins; Escherichia coli; Female; Horse Diseases; Horses; Iodine Radioisotopes; Kinetics; Male; Platelet Activating Factor; Serum Albumin; Tachyphylaxis; Zymosan | 1995 |
Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice.
Topics: Acute Disease; Anaphylaxis; Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Cell Movement; Crosses, Genetic; Cysteine; Dermatitis, Contact; Ear; Epoxide Hydrolases; Fluorescein-5-isothiocyanate; Immunoglobulin E; Inflammation Mediators; Leukotriene B4; Leukotrienes; Lipopolysaccharides; Mice; Mice, Knockout; Neutrophils; Peritonitis; Platelet Activating Factor | 1999 |
Differential activation of platelets from normal and allergic ponies by PAF and ADP.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adenosine Diphosphate; Animals; Dermatitis, Contact; Eicosanoids; Horse Diseases; Horses; Hypersensitivity, Immediate; Platelet Activating Factor; Platelet Activation; Seasons; Serotonin; Signal Transduction; Thromboxane B2 | 2000 |
Site of anti-inflammatory action of dexamethasone in rabbit skin.
Topics: Animals; Bradykinin; Dactinomycin; Dermatitis, Contact; Dexamethasone; Dinoprostone; Female; Histamine; Leukotriene B4; Male; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Protein Biosynthesis; Rabbits; RNA; Skin; Zymosan | 1991 |
Pharmacologic modulation of picryl chloride-induced contact dermatitis in the mouse.
Topics: Animals; Betamethasone; Dermatitis, Contact; Dose-Response Relationship, Drug; Indomethacin; Lactones; Male; Methysergide; Mice; Mice, Inbred BALB C; Picryl Chloride; Plant Extracts; Platelet Activating Factor | 1991 |
Effect of BN 52021, a platelet activating factor antagonist, on dithranol-induced inflammation.
Topics: Adult; Anthralin; Capillary Resistance; Dermatitis, Contact; Diterpenes; Female; Ginkgolides; Humans; Lactones; Male; Middle Aged; Platelet Activating Factor; Skin; Skin Temperature; Skinfold Thickness | 1990 |
Effects of alprazolam on platelet activating factor-induced wealing.
Topics: Adult; Alprazolam; Dermatitis, Contact; Humans; Platelet Activating Factor | 1989 |
A simple method for studying chemotaxis, vascular permeability and histological modifications induced by mediators of inflammation in vivo in man.
Topics: Capillary Permeability; Chemotaxis, Leukocyte; Dermatitis, Contact; Humans; Leukotriene B4; Methods; Platelet Activating Factor; Skin | 1985 |
Involvement of arachidonate-dependent lipid mediators and platelet-activating factor in experimental murine contact dermatitis.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Capillary Permeability; Croton Oil; Dermatitis, Contact; Dinitrofluorobenzene; Ear, External; Female; Lipids; Lipoxygenase Inhibitors; Mice; Mice, Inbred BALB C; Platelet Activating Factor | 1988 |
Effect of BN 52021, a platelet activating factor antagonist, on experimental murine contact dermatitis.
Topics: Animals; Dermatitis, Contact; Dinitrofluorobenzene; Disease Models, Animal; Diterpenes; Female; Ginkgolides; Lactones; Mice; Mice, Inbred BALB C; Platelet Activating Factor; Skin | 1988 |
Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man.
Topics: Adult; Cell Movement; Dermatitis, Contact; Histiocytes; Humans; Lymphocytes; Neutrophils; Platelet Activating Factor; Skin | 1985 |